Sun Pharma to acquire Japan's Pola Pharma for USD 1 mn
Pola Pharma's portfolio mainly comprises dermatology products. It has two manufacturing facilities in Saitama with capabilities to manufacture topical products and injectables.
Nov 27, 2018, 10:55 AM IST
Sun Pharma arm to acquire shares of Israeli firm Tarsius Pharma for $3 million
Indicative time period for completion of the acquisition is before September 15, 2018, Sun Pharma said.
Sep 10, 2018, 17:25 PM IST
Sun Pharma to acquire oncology product from Novartis for $175 million
Drug major Sun Pharmaceutical Industries on Thursday said it it will acquire a branded oncology product, Odomzo, from Novartis for an upfront payment of USD 175 million.
Dec 22, 2016, 11:21 AM IST
